Premature rupture of the membranes -further results with the use of PVP-iodine for prevention of aäcending infection and clinical management E.Saling, B. Weßmann, Berlin
The permanent Infusion of highly diluted PVP-iodine solution into the vagina in cases of premature rupture of membranes has been introduced three years ago in German (1) and two years ago in English (2) literature* Results For this panel we prepared a new evaluation, concerning the most important clinical success criteria, preferably the infant morbidity and mortality caused by infection (Tab. 1). During the period from January 1977
to December 198O, 161 premature infant s ( <37/O weäcs of gestation) born after a latency period of more than 18 hours after premature rupture of membranes and vaginal PVP-iodine prophylaxis, no infant died in the whole neonatal period (Ist to 28th Comparison of morbidity and mortality of premature infants ( < 37/0 pregnancy weeks, birthweight > 1000 g) in the newborn period (1-28 day of life) after early rupture of the membranes (latency: rupture-birth > 18 hours). day of life). The Tab. 1 mortality during the period before the application of PVP-iodine lay in the region of 6.5% in our department; related to our present material of 161 cases, this would be 1O or 11 infants.
Clinical procedure
Average gestational age, birthweight and the 10th, 50th and 90th percentile for the latency period between rupture of membranes and birth. A direct statistical comparison of the two groups cannot be given in füll äs they were taken from different periods. However the results are nevertheless very informative äs, in the previous period before application of PVPiodine, we tended 0300-5^77/82/0102^0006 g 2.0O Copyright by Walter de Gruyter & Co.
to a more active management, which would rather reduce infection morbidity and mortality. The more active management is reflected through the shorter latency period between premature rupture of membranes and the birth (Tab. 2).
When considering infant morbidity caused by infection it is shown (Tab. 1) that this is only less in the group of 126 infants which received the PVP-iodine application within 4 hours after rupture of the membranes out of the total of 161 who received PVP-iodine treatment at all.
In the remaining group of 35 infants where the PVPiodine application was not started within 4 hours after rupture the morbidity was higher, twice äs high äs in the period before the use of PVP-iodine, but fortunately none of the.se infants died from severe infection during the neonatal period. In any case it's recommendable to achieve the shortest possible latency period between rupture of membranes and PVP-iodine application.
Side effects of iodine-resorption After premature rupture of the membranes and PVP-iodine prophylaxis, the fetus is very probably not directly exposed to the PVP-iodine solution. However vaginal iodine-resorption can occur through the mother, which can lead to an iodine increase in the fetal blood and can interfere with the thyroid function of the newborn.
In order to elucidate whether we are dealing with a harmful and lasting or a transient and tolerable effect, the TSH and thyroid hormone concentrations of these newborn and of all newborn whose mothers received PVPiodine infection prophylaxis during intensive monitoring throughout the labor -altogether 1045 infants -have been investigated (Tab. 3). This is a cooperative study with the Department of Pediatrics of the Free University.of Berlin. We found in 1O4 cases elevated TSH-values of more than 20 ;iU/ml, and in 13 cases of more than 50 pU/ml. These newborn have been contfolled until normalization. We were reassured to find that the striking alterations of TSH and thyroid hormones did not last longer than 10 days.
As far äs such a transient depression of thyroid activity is not taken äs an indication for substitutdve therapy by pediatric endocrinologists, we can accept the Situation when careful control and follow up examinations are guaranteed. However, these TSR elevations may Imitate changes found in congenital hypothyroidism, and thereby cause anxiety in parents and the responsible doctor.
Therefore, close cooperation between the obstetrician using £>VP-iodine and the screening laboratory is important, in order to avoid unnecessary diagriostic and therapeutic procedures in these infants ön the one hand, and on the other hand not to miss an early treatment of true congenital hyp o thyroid i situ
Due to the possibility of iodine resorption occurririg •through the mother, all pregnant women should be excluded from this therapy who have had thyroid illness in the past.
If in the future other suitable disinfectant Solutions without any negative side-effects could be foünd f then it could be recommendable to renounce on the üse of Solutions containing iodine.
At the present time we use the following clinical procedure in cases of eairly rupture of membranes: a) Using PVP-iodine prophylaxis, if necessary bombined with tocolytic::therapy (application of betamimetics) f we wait when possible until the pregnancy has reached 35 completed weeks. Up to this point the fetus has grown sufficiently not to be particularly endangered äs it is close to ternu Also the chances are much better for the newborn not to be separated too long from his möther if at all. b) At the very beginning of our management we give -if the gestational age is 26 weeks -lung maturation treatment consisting of four doses of 4 mg Betamethason every 12 hours. c) From the 36th week of gestation onwards we discontinue the tocolytic therapy and wait some hours until spontaneous labor Starts. If this is not the case and cervix ripeness is given (Bishop Score >7 f better >8), we induce labor by oxytocin infusion. We Start with O.5 mU and increase the dose every 5 minutes by O.5 mU respectively. If cervix ripeness is insufficient we apply PG-Gel (O.4 mg = 40 g PGE p ) into the cervix and wait until a sufficient ripeness is achieved and then induce labor actively. 
